Using renewable energy, OMV will produce up to 23,000 tons of green hydrogen per year ... OMV's Schwechat refinery ... Together, these investments support OMV's ambition to achieve net-zero emissions by 2050.
The EuropeanInvestment Bank (EIB) has granted a €450 MM loan to support the construction of OMV’s green hydrogen production plant, which is set to significantly contribute to the decarbonization of the Schwechat refinery in Lower Austria....
DX-104 is an innovative Group B meningococcal (MenB) vaccine candidate developed using the company's proprietary OMVPlus® platform ... About DX-104(MenB OMV vaccine). DX-104 is a Group B meningococcal OMV ...
This trading update provides provisional basic information on the economic environment as well as OMV's key performance indicators for the quarter ended June 30, 2026 ... About OMV ... OMV is striving to achieve net zero by 2050 at the latest.
About the OMVPlatform... The Phase I study was a first-in-human, randomized, double-blind, placebo- and OMV-controlled clinical trial conducted in 40 healthy SARS-CoV-2 seropositive adults aged 18–55 years.